Oman Pharmaceutical Products Co. LLC (manufacturing, packaging, quality control of medicinal product batch)
UkraineAll drugs from this manufacturer
-
The drug is used for the primary prevention of venous thromboembolic complications in adult patients who have undergone major orthopedic surgery for knee or hip replacement.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC: B01AE07
-
The drug is used to prevent venous thromboembolic complications following hip or knee replacement surgery. It is also prescribed to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment and prevention of recurrences of deep vein thrombosis and pulmonary embolism.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC: B01AE07
-
The drug is used to prevent stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis and pulmonary embolism, as well as for the prevention of their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC: B01AE07